UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...
A new study reveals how targeted electromagnetic waves can disrupt the SARS-CoV-2 spike protein, potentially opening doors to innovative disinfection and infection control strategies. Study: ...
Researchers have discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly ...
The question of the origin of SARS-CoV-2 continues to occupy scientists, the media, and the public intensely even 5 years after the onset of the COVID-19 pandemic. Where the virus came from, when and ...
Researchers have discovered that SARS-CoV-2, the virus that causes COVID-19, may be changing crucial white blood cells called neutrophils so that instead of working to destroy pathogens, they instead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results